Effect of ginger (Zingiber officinale Rosc.) and fenugreek (Trigonella foenumgraecum L.) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease.
In a placebo-controlled study the effect of ginger and fenugreek was examined on blood lipids, blood sugar, platelet aggregation, fibrinogen and fibrinolytic activity. The subjects included in this study were healthy individuals, patients with coronary artery disease (CAD), and patients with non-insulin-dependent diabetes mellitus (NIDDM) who either had CAD or were without CAD. In patients with CAD powdered ginger administered in a dose of 4 g daily for 3 months did not affect ADP- and epinephrine-induced platelet aggregation. Also, no change in the fibrinolytic activity and fibrinogen level was observed. However, a single dose of 10 g powdered ginger administered to CAD patients produced a significant reduction in platelet aggregation induced by the two agonists. Ginger did not affect the blood lipids and blood sugar. Fenugreek given in a dose of 2.5 g twice daily for 3 months to healthy individuals did not affect the blood lipids and blood sugar (fasting and post prandial). However, administered in the same daily dose for the same duration to CAD patients also with NIDDM, fenugreek decreased significantly the blood lipids (total cholesterol and triglycerides) without affecting the HDL-c. When administered in the same daily dose to NIDDM (non-CAD) patients (mild cases), fenugreek reduced significantly the blood sugar (fasting and post prandial). In severe NIDDM cases, blood sugar (both fasting and post prandial) was only slightly reduced. The changes were not significant. Fenugreek administration did not affect platelet aggregation, fibrinolytic activity and fibrinogen.
Bordia
A
A
Department of Medicine, R.N.T. Medical College, Udaipur, India.
Verma
S K
SK
Srivastava
K C
KC
D001095:Arachidonic Acids / Q000378:metabolism; D001786:Blood Glucose / Q000187:drug effects; D001792:Blood Platelets / Q000378:metabolism; D003327:Coronary Disease / Q000097:blood* / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications; D004347:Drug Interactions; D004837:Epinephrine / Q000494:pharmacology; D006801:Humans; D008055:Lipids / Q000097:blood; D010919:Placebos; D010936:Plant Extracts; D010946:Plants, Medicinal; D010974:Platelet Aggregation / Q000187:drug effects; D017365:Spices; D029910:Trigonella
D001095:Arachidonic Acids; D001786:Blood Glucose; D008055:Lipids; D010919:Placebos; D010936:Plant Extracts; C056164:fenugreek seed meal; D004837:Epinephrine